Effects of Neo40(TM) With Caffeine on Cycling Time Trial Performance

Status unconfirmed · Not applicable · Has a placebo group

Conditions studied: Healthy

In brief

Acute supplementation of Neo40(TM), a nitrate lozenge, will improve cycling performance

Key facts

Study ID

NCT01710761

Run by

University of Texas at Austin

People needed

16

Starts

2012-10-01

Expected to finish

2013-05-01

Last updated by the study team

2013-01-23

Who can join

Age: 21 and older, up to 49. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Regular commuter cyclist or spin class participant
• Male (VO2max < 50) or Female (VO2max < 45)
• Healthy
• Blood pressure below 140/90
• Non-smoker

You may not qualify if…

• Does not cycle 2-3 times/week
• Regular consumption of performance-enhancing substances
• Type I or Type II diabetes
• Renal, hepatic or cardiac disease
• Current infectious disease

Where it is running

• The University of Texas at Austin — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.